Portman LTD Vera Therapeutics, Inc. Transaction History
Portman LTD
- $29.6 Million
- Q3 2024
A detailed history of Portman LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Portman LTD holds 32,795 shares of VERA stock, worth $937,281. This represents 4.9% of its overall portfolio holdings.
Number of Shares
32,795
Previous 32,795
-0.0%
Holding current value
$937,281
Previous $1.19 Million
22.18%
% of portfolio
4.9%
Previous 4.51%
Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...